IL10 and Alzheimer disease: At the same time, selection bias in banked biospecimens may account for reduced IL-10 levels in MCI+ compared with AD as lower IL-10 levels were associated with greater rates of memory decline, a feature often considered when MCI samples are selected retrospectively.